MW 240.68 Da, Purity >99%. α2 Adrenoceptor antagonist and I2 ligand. Improves motor symptoms and decreases dyskinesia in Parkinson's disease models. Also induces apoptosis. Active *in vivo*.
ADA1D_HUMAN, ADA2A_HUMAN, ADA2C_HUMAN, ADRA1A, ADRA1L1, ADRA2, ADRA2A, ADRA2L2, ADRA2R, ADRA2RL1, ADRA2RL2, ADRAR, ADRARL1, ADRARL2, AI838772, AW493413, Adra 2c, Adra1d, Adrenergic alpha 1A receptor, Adrenergic alpha 1B receptor, Adrenergic alpha 1C receptor, Adrenergic alpha 1D receptor, Adrenergic alpha 2A receptor, Adrenergic alpha 2C receptor, Adrenoceptor alpha 2C, Alpha 2 adrenergic receptor subtype C2, Alpha 2AAR subtype C10, Alpha 2B adrenoceptor, Alpha 2B adrenoreceptor, Alpha 2C adrenergic receptor subtype C4, Alpha adrenergic receptor 1b, Alpha adrenergic receptor 1d, Alpha-1A adrenergic receptor, Alpha-1A adrenoreceptor, Alpha-1C adrenergic receptor, Alpha-1D adrenergic receptor, Alpha-1D adrenoceptor, Alpha-1D adrenoreceptor, Alpha-2 adrenergic receptor subtype C10, Alpha-2 adrenergic receptor subtype C4, Alpha-2-adrenergic receptor, renal type, Alpha-2A adrenergic receptor, Alpha-2A adrenoceptor, Alpha-2A adrenoreceptor, Alpha-2AAR, Alpha-2C adrenergic receptor, Alpha-2C adrenoceptor, Alpha-2C adrenoreceptor, Alpha-2CAR, Alpha-adrenergic receptor 1a, Alpha-adrenergic receptor 1c, DNA replication inhibitor, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ESRL 1, ESRR A, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen-related receptor alpha, Estrra, FLJ11090, GEMI_HUMAN, GMNN, Geminin, Geminin DNA replication inhibitor, MGC104252, MGC112732, NR3B1, Nuclear receptor subfamily 3 group B member 1, OTTHUMP00000039393, OTTHUMP00000058849, RP24-311F12.2, RP3 369A17.3, SCAN1, Steroid hormone receptor ERR1, Subtype alpha2 C4, TYDP, TYDP1_HUMAN, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, alpha 2BAR, alpha-2-adrenergic receptor, platelet type, alpha2 AR C4, alpha2 C4, alpha2C, alpha2cii-adrenergic receptor, estrogen receptor related receptor alpha, hERR1
MW 240.68 Da, Purity >99%. α2 Adrenoceptor antagonist and I2 ligand. Improves motor symptoms and decreases dyskinesia in Parkinson's disease models. Also induces apoptosis. Active *in vivo*.
Soluble in water to 100 mM.
α2 Adrenoceptor antagonist and I2 ligand. Improves motor symptoms and decreases dyskinesia in Parkinson's disease models. Also induces apoptosis. Active *in vivo*.
The alpha-2 adrenergic receptors including receptor subtypes like ADRA2B ADRA2C and alpha-2A function as G protein-coupled receptors that inhibit the release of norepinephrine and other neurotransmitters in the central and peripheral nervous system. These receptors have a mass close to 50 kDa and express in various tissues including the brain spinal cord and vascular smooth muscles. Additionally Idazoxan acts as an antagonist ligand for these receptors. Another key protein TDP1 is known for its role in DNA repair processes while Geminin is involved in regulating DNA replication. Moreover Estrogen Related Receptor alpha (ERRα) is a nuclear receptor that influences metabolic processes.
Alpha-adrenergic receptors including the ADRA2B and ADRA2C modulate neurochemical release and vascular tone contributing to responses such as vasoconstriction and lowering of blood pressure. Not functioning alone these receptors can be part of larger receptor complexes that coordinate multiple signal cascades. TDP1 plays a significant role in maintaining DNA integrity collaborating with other DNA repair proteins. Geminin on the other hand ensures proper DNA replication without over-replication. ERRα regulates energy homeostasis and lipid metabolism through its influence on gene transcription-related pathways.
The alpha-2 adrenergic receptors participate significantly in adrenergic signaling impacting cellular responses to stress and metabolic function. They involve proteins such as G-proteins and other neurotransmitter-related proteins. Meanwhile TDP1 is essential in the DNA repair pathway associated with phosphodiester bonds and is linked to proteins engaged in coordinating DNA damage responses. ERRα operates within metabolic pathways particularly influencing pathways related to mitochondrial biogenesis and oxidative phosphorylation alongside key metabolic enzymes.
Dysregulation of alpha-2 adrenergic receptors links to hypertension and stress-related conditions as they impact cardiovascular and nervous system functions. Their altered function might also engage different adrenergic receptor subtypes impacting other physiological responses. TDP1 mutations can associate with neurodegenerative disorders like Huntington's disease implicating proteins involved in DNA repair cascades. Meanwhile ERRα has been connected with metabolic diseases such as diabetes linking it to disorders through altered metabolic protein interactions.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab141130, Idazoxan hydrochloride, alpha2Adrenoceptor antagonist and I2 ligand
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com